NewAmsterdam Pharma Company N.V. Ordinary Shares Free Cash Flow Generation Index
NewAmsterdam Pharma Company N.V. Ordinary Shares free cash flow generation index. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $29.08 Million represents 1% of operating cash flow ($29.19 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Free cash flow generation index of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2022 to 2022. Historical FCF Generation Index trend for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. See NAMS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
NewAmsterdam Pharma Company N.V. Ordinary Shares Free Cash Flow Generation Index by Year (2022–2022)
NewAmsterdam Pharma Company N.V. Ordinary Shares free cash flow generation index by year from 2022 to 2022. Year-by-year Free Cash Flow Generation Index for NewAmsterdam Pharma Company N.V. Ordinary Shares. For the full cash flow conversion analysis, see NAMS cash flow metrics.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.98x | $10.44 Million | $10.66 Million | $221.00K | — |